Literature DB >> 26364767

Familial recurrences of FOXG1-related disorder: Evidence for mosaicism.

Kelly Q McMahon1, Apostolos Papandreou2,3,4, Mandy Ma5, Brenda J Barry6, Ghayda M Mirzaa7, William B Dobyns7, Richard H Scott4,8, Natalie Trump8, Manju A Kurian2,3, Alex R Paciorkowski1,9.   

Abstract

FOXG1-related disorders are caused by heterozygous mutations in FOXG1 and result in a spectrum of neurodevelopmental phenotypes including postnatal microcephaly, intellectual disability with absent speech, epilepsy, chorea, and corpus callosum abnormalities. The recurrence risk for de novo mutations in FOXG1-related disorders is assumed to be low. Here, we describe three unrelated sets of full siblings with mutations in FOXG1 (c.515_577del63, c.460dupG, and c.572T > G), representing familial recurrence of the disorder. In one family, we have documented maternal somatic mosaicism for the FOXG1 mutation, and all of the families presumably represent parental gonadal (or germline) mosaicism. To our knowledge, mosaicism has not been previously reported in FOXG1-related disorders. Therefore, this report provides evidence that germline mosaicism for FOXG1 mutations is a likely explanation for familial recurrence and should be considered during recurrence risk counseling for families of children with FOXG1-related disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  14q12; FOXG1; familial recurrence; gonadal mosaicism

Mesh:

Substances:

Year:  2015        PMID: 26364767      PMCID: PMC4715619          DOI: 10.1002/ajmg.a.37353

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  30 in total

Review 1.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

2.  Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics.

Authors:  Ian M Campbell; Jonathan R Stewart; Regis A James; James R Lupski; Paweł Stankiewicz; Peter Olofsson; Chad A Shaw
Journal:  Am J Hum Genet       Date:  2014-09-18       Impact factor: 11.025

3.  Recurrence risk for germinal mosaics revisited.

Authors:  M A van der Meulen; M J van der Meulen; G J te Meerman
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

4.  West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14.

Authors:  Jun Tohyama; Toshiyuki Yamamoto; Kana Hosoki; Keisuke Nagasaki; Noriyuki Akasaka; Tsukasa Ohashi; Yu Kobayashi; Shinji Saitoh
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

5.  Recurrence risk of a new dominant mutation in children of unaffected parents.

Authors:  E M Wijsman
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

6.  FOXG1-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  C Florian; N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-04-29

7.  Risk estimation in autosomal dominant disorders with reduced penetrance.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

8.  Novel FOXG1 mutations associated with the congenital variant of Rett syndrome.

Authors:  M A Mencarelli; A Spanhol-Rosseto; R Artuso; D Rondinella; R De Filippis; N Bahi-Buisson; J Nectoux; R Rubinsztajn; T Bienvenu; A Moncla; B Chabrol; L Villard; Z Krumina; J Armstrong; A Roche; M Pineda; E Gak; F Mari; F Ariani; A Renieri
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

9.  A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features.

Authors:  Filomena Tiziana Papa; Maria Antonietta Mencarelli; Rossella Caselli; Eleni Katzaki; Katia Sampieri; Ilaria Meloni; Francesca Ariani; Ilaria Longo; Angela Maggio; Paolo Balestri; Salvatore Grosso; Maria Angela Farnetani; Rosario Berardi; Francesca Mari; Alessandra Renieri
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

10.  FOXG1 is responsible for the congenital variant of Rett syndrome.

Authors:  Francesca Ariani; Giuseppe Hayek; Dalila Rondinella; Rosangela Artuso; Maria Antonietta Mencarelli; Ariele Spanhol-Rosseto; Marzia Pollazzon; Sabrina Buoni; Ottavia Spiga; Sara Ricciardi; Ilaria Meloni; Ilaria Longo; Francesca Mari; Vania Broccoli; Michele Zappella; Alessandra Renieri
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

View more
  8 in total

1.  Expanding the neurodevelopmental phenotype of PURA syndrome.

Authors:  Bo Hoon Lee; Margot R F Reijnders; Oluwatobi Abubakare; Emily Tuttle; Brynn Lape; Kelly Q Minks; Christopher Stodgell; Loisa Bennetto; Jennifer Kwon; Chin-To Fong; Karen W Gripp; Eric D Marsh; Wendy E Smith; Ahm M Huq; Stephanie A Coury; Wen-Hann Tan; Orestes Solis; Rupal I Mehta; Richard J Leventer; Diana Baralle; David Hunt; Alex R Paciorkowski
Journal:  Am J Med Genet A       Date:  2017-11-17       Impact factor: 2.802

2.  A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.

Authors:  Chloe M Reuter; Elise Brimble; Colette DeFilippo; Annika M Dries; Gregory M Enns; Euan A Ashley; Jonathan A Bernstein; Paul Graham Fisher; Matthew T Wheeler
Journal:  J Pediatr       Date:  2018-01-11       Impact factor: 4.406

3.  FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.

Authors:  Diana Mitter; Milka Pringsheim; Marc Kaulisch; Kim Sarah Plümacher; Simone Schröder; Rita Warthemann; Rami Abou Jamra; Martina Baethmann; Thomas Bast; Hans-Martin Büttel; Julie S Cohen; Elizabeth Conover; Carolina Courage; Angelika Eger; Ali Fatemi; Theresa A Grebe; Natalie S Hauser; Wolfram Heinritz; Katherine L Helbig; Marion Heruth; Dagmar Huhle; Karen Höft; Stephanie Karch; Gerhard Kluger; G Christoph Korenke; Johannes R Lemke; Richard E Lutz; Steffi Patzer; Isabelle Prehl; Konstanze Hoertnagel; Keri Ramsey; Tina Rating; Angelika Rieß; Luis Rohena; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Barbara Zoll; Dörthe Malzahn; Birgit Zirn; Knut Brockmann
Journal:  Genet Med       Date:  2017-06-29       Impact factor: 8.822

4.  Structural brain anomalies in patients with FOXG1 syndrome and in Foxg1+/- mice.

Authors:  Milka Pringsheim; Diana Mitter; Simone Schröder; Rita Warthemann; Kim Plümacher; Gerhard Kluger; Martina Baethmann; Thomas Bast; Sarah Braun; Hans-Martin Büttel; Elizabeth Conover; Carolina Courage; Alexandre N Datta; Angelika Eger; Theresa A Grebe; Annette Hasse-Wittmer; Marion Heruth; Karen Höft; Angela M Kaindl; Stephanie Karch; Torsten Kautzky; Georg C Korenke; Bernd Kruse; Richard E Lutz; Heymut Omran; Steffi Patzer; Heike Philippi; Keri Ramsey; Tina Rating; Angelika Rieß; Mareike Schimmel; Rachel Westman; Frank-Martin Zech; Birgit Zirn; Pauline A Ulmke; Godwin Sokpor; Tran Tuoc; Andreas Leha; Martin Staudt; Knut Brockmann
Journal:  Ann Clin Transl Neurol       Date:  2019-03-03       Impact factor: 4.511

5.  Beyond the Exome: The Non-coding Genome and Enhancers in Neurodevelopmental Disorders and Malformations of Cortical Development.

Authors:  Elena Perenthaler; Soheil Yousefi; Eva Niggl; Tahsin Stefan Barakat
Journal:  Front Cell Neurosci       Date:  2019-07-31       Impact factor: 5.505

6.  A rare mosaic 22q11.2 microdeletion identified in a Chinese family with recurrent fetal conotruncal defects.

Authors:  Weicheng Chen; Xiaodi Li; Liqun Sun; Wei Sheng; Guoying Huang
Journal:  Mol Genet Genomic Med       Date:  2019-07-11       Impact factor: 2.183

Review 7.  The Gut-Brain-Microbiome Axis and Its Link to Autism: Emerging Insights and the Potential of Zebrafish Models.

Authors:  David M James; Elizabeth A Davidson; Julio Yanes; Baharak Moshiree; Julia E Dallman
Journal:  Front Cell Dev Biol       Date:  2021-04-15

8.  Novel FOXG1 mutations in Chinese patients with Rett syndrome or Rett-like mental retardation.

Authors:  Qingping Zhang; Jiaping Wang; Jiarui Li; Xinhua Bao; Ying Zhao; Xiaoying Zhang; Liping Wei; Xiru Wu
Journal:  BMC Med Genet       Date:  2017-08-29       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.